Andrea Fava

Andrea Fava is an expert in lupus nephritis diagnostics, while Chris Winkup is a consultant rheumatologist focused on CAR-T therapy. They dive into the challenges of diagnosing lupus nephritis with new non-invasive biomarkers. The discussion highlights the impact of positive ANA patterns on liver disease, and the advancements in CAR-T therapy for targeting harmful B-cells. They also touch upon vaccination responses and the complexities surrounding neuropsychiatric lupus, emphasizing the need for enhanced patient-clinician communication.

Dr. Andrea Fava, a researcher specializing in autoimmune diseases, discusses groundbreaking research on fibroblasts and their role in conditions like lupus. She introduces an innovative urinary biomarker that could revolutionize lupus nephritis diagnosis. The podcast also highlights legislative efforts for better healthcare access and underscores the importance of monitoring cardiovascular health in autoimmune patients. Additionally, discussions touch on gender differences in disease management, advocating for tailored approaches to improve patient outcomes.

Rheumatology specialists Drs. Cush, Yusof, and Fava discuss cutting-edge lupus therapies at EULAR 2024 conference. Topics include steroid reduction strategies, B-cell targeting meds, and promising results of ionolumab for cell depletion. They delve into Lupus treatment trials, advances in lupus nephritis therapies, biomarkers for disease activity prediction, and the dynamic nature of lupus nephritis.